AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| GNE | Ann: Notice of Issue of New Ordinary Shares | 20/04/18 | 0 | 17 | |||
|
|||||||
| GNE | Ann: General Counsel Appointment | 20/04/18 | 0 | 16 | |||
|
|||||||
| GNE | Ann: FY18 Q3 Performance Report | 17/04/18 | 0 | 23 | |||
|
|||||||
| GNE | Ann: Board Announcement - Director Appointment | 16/04/18 | 0 | 30 | |||
|
|||||||
| GNE | Ann: 2018 Interim Dividend Reinvestment Plan Strike Price | 12/04/18 | 0 | 25 | |||
|
|||||||
| GNE | Ann: Ongoing Disclosure Notices – Multiple | 29/03/18 | 0 | 31 | |||
|
|||||||
| GNE | Ann: Shareholder Webcast Q&A Event | 21/03/18 | 0 | 34 | |||
|
|||||||
| GNE | Ann: D&O Ongoing Disclosures - Multiple | 28/02/18 | 0 | 35 | |||
|
|||||||
See All Discussions
NZX News